Abstract
A series of hitherto unknown (1,4-disubstituted-1,2,3-triazol)-(E)-2-methyl-but-2-enyl nucleosides phosphonate prodrugs bearing 4-substituted-1,2,3-triazoles were prepared in a straight approach through an olefin acyclic cross metathesis as the key synthetic step. All novel compounds were evaluated for their antiviral activities against HBV, HIV and SARS-CoV-2. Among these molecules, only compound 15j, a hexadecyloxypropyl (HDP)/(isopropyloxycarbonyl-oxymethyl)-ester (POC) prodrug, showed activity against HBV in Huh7 cell cultures with 62% inhibition at 10 μM, without significant cytotoxicity (IC50 = 66.4 μM in HepG2 cells, IC50 = 43.1 μM in HepG2 cells) at 10 μM.
Funder
National Institutes of Health
Laboratoire d'Excellence SYNORG
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference28 articles.
1. Nucleoside and nucleotide analogues for the treatment of herpesvirus infections: Current stage and new prospects in the field of acyclic nucleoside phosphonates;Krečmerová,2012
2. Current Protocols in Nucleic Acid Chemistry;Holý,2005
3. Acyclic nucleoside phosphonates: a key class of antiviral drugs
4. Acyclic nucleoside phosphonates: An unfinished story
5. Prodrugs of phosphonates and phosphates: Crossing the membrane barrier;Wiemer;Top. Curr. Chem.,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献